Funded Tech Companies
Verve Therapeutics
Looking for the VC firms that backed Verve Therapeutics? GV, Novo Ventures and Wellington Management Company joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Verve Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
500 Technology Sq. 901
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/17/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Burt Adelman
Chief Executive Officer
Sekar Kathiresan
Chief Scientific Officer
Andrew Bellinger
Co-Founder
Keith Joung
Co-Founder
Kiran Musunuru
Co-Founder
Anthony Philippakis
Co-Founder
Issi Rozen
Co-Founder
Barry Ticho
President
Andrew Ashe
Vice President
Kallanthottathil Rajeev
Vice President
Ellen Rohde
VP - Manufacturing
Christopher Cheng
VP - Marketing
Michele Rozen
VP - R & D
Alexandra Chadwick
VP - Regulatory Affairs
Leslie Stolz
Company Investors
- GV (Krishna Yeshwant)
- Novo Ventures
- Wellington Management Company (Robert Deresiewicz)
- Rock Springs Capital
- Logos Capital
- RA Capital
- Biomatics Capital Partners
- Casdin Capital (Eli Casdin)
- Cormorant Asset Management
- Redmile Group
- Janus Henderson Investors
- Surveyor Capital
- F-Prime Capital
- Arch Venture Partners (John Evans)
Browse more funded tech companies:
Verve Motion | Very Good Security
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs